Adam Dixon: How AI-Powered Ultrasound Can Optimize Neuraxial Anesthesia for Anticoagulated Patients
Adam Dixon, Chief Technology Officer of RIVANNA, shared a post on LinkedIn:
“Administering neuraxial anesthesia in patients on anticoagulants presents a nuanced risk profile, particularly when it comes to the potential for spinal hematomas. When the timing and management of anticoagulants aren’t fully aligned with procedural guidelines, anticoagulation therapy can increase the likelihood of bleeding during epidural and spinal anesthesia.
The question is: How can we better mitigate these risks while ensuring optimal pain management?
Neuraxial techniques offer localized pain relief, generally considered safer than general anesthesia for people taking anticoagulants. This helps to decrease the perioperative risk of blood clots, effectively lowering the demand for systemic anticoagulants postoperatively. Ultrasound guidance can enhance precision by providing high-resolution imaging of vascular structures and anatomical landmarks. And by improving pre-procedural planning in this way, ultrasound helps reduce the likelihood of vascular complications, supporting safer outcomes.

AI-powered ultrasound can improve precision in neuraxial anesthesia for patients on anticoagulants. Visit here to learn more.”
Discover the latest on Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology
